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OBJECTIVE — To determine the microbiological proﬁle of diabetes-related foot infections
(DRFIs) and the impact of wound duration, inpatient treatment, and chronic kidney disease (CKD).
RESEARCH DESIGN AND METHODS — Postdebridement microbiological samples
were collected from individuals presenting with DRFIs from 1 January 2005 to 31 December 2007.
RESULTS — A total of 653 specimens were collected from 379 individuals with 36% identi-
fyingonlyoneisolate.Ofthetotalisolates,77%weregram-positivebacteria(staphylococci43%,
streptococci 13%). Methicillin-resistant Staphylococcus aureus (MRSA) was isolated from 23%;
risk factors for MRSA included prolonged wound duration (odds ratio 2.31), inpatient manage-
ment (2.19), and CKD (OR 1.49). Gram-negative infections were more prevalent with inpatient
management (P  0.002) and prolonged wound duration (P  0.001). Pseudomonal isolates
were more common in chronic wounds (P  0.001).
CONCLUSIONS — DRFIs are predominantly due to gram-positive aerobes but are usually
polymicrobial and increase in complexity with inpatient care and ulcer duration. In the presence of
prolonged duration, inpatient management, or CKD, empiric MRSA antibiotic cover should be
considered.
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T
his study was undertaken to evalu-
ate microbiological specimens col-
lected from patients with diabetes-
related foot infections (DRFIs) and
managed by a multidisciplinary diabetic
foot unit (DFU). The primary aim was to
determine the prevalence of bacterial iso-
lates including methicillin-resistant
Staphylococcus aureus (MRSA). The sec-
ondary aim was to characterize the effect
of wound duration, inpatient treatment,
and chronic kidney disease (CKD) on the
microbiological proﬁle.
RESEARCH DESIGN AND
METHODS— All individuals man-
aged by a DFU between 1 January 2005
and 31 December 2007 were prospec-
tively recruited. Eligibility criteria re-
quired the coexistence of diabetes and an
infected pedal wound. Pedal wounds
were deﬁned as an epithelial breach distal
to the ankle, while clinical infection was
deﬁned as the presence of a purulent dis-
charge or two or more of erythema,
warmth, tenderness, or induration (1,2).
Wounds were deemed acute if present for
less than 6 weeks. Consistent with the
Kidney Disease Outcomes Quality Initia-
tive guidelines, CKD was diagnosed if the
estimated glomerular ﬁltration rate was
60 ml   min
1   1.73 m
1 (2) for more
than 3 months (3).
Baseline data were recorded, in-
cluding age, sex, diabetes duration,
A1C,diabetestreatment,priorinpatient
management, and estimated glomerular
ﬁltration rate. Inpatient management was
deﬁned as at least an overnight stay for
any condition during the existence of the
pedal wound. Microbiological specimens
were collected by a member of the DFU
from the base of all clinically infected
wounds and consisted of either a postde-
bridement wound swab or tissue sample
(subcutaneous tissue or bone). Bone bi-
opsieswerecollectedbycomputerizedto-
mography guidance. If an individual had
more than one wound, appropriate mi-
crobiologicalsampleswerecollectedfrom
eachclinicallyinfectedwound.Microbio-
logical analyses included Gram staining
and aerobic and anaerobic cultures.
Ethics approval was obtained from
the Melbourne Health Human Research
Ethics Committee. Statistical analysis was
undertaken with Stata 10.0 (StataCorp,
College Station, TX), with a P value
0.05 considered statistically signiﬁcant.
TheWilcoxon’srank-sumtestwasusedto
calculate P values for continuous data,
and Fisher’s exact test was used for all
other univariate statistical analyses. Mul-
tivariate analyses were performed using
stepwise logistic regression.
RESULTS— A total of 379 patients
were identiﬁed as having a DRFI (mean
age 67 years [range 22–93], mean A1C
8.0%). Seventy-one percent of the indi-
viduals were men, but the percentage of
women treated increased signiﬁcantly
during the study period (20% in 2005,
35% in 2007, P  0.0071). Mean dia-
betes duration was 18 years, and 88%
had type 2 diabetes (51% insulin re-
quiring, 31% on oral medication, and
6% on diet alone). Eighty-three percent
of the individuals received inpatient
management care, but during the study
period the proportion of individuals
managed exclusively on an outpatient
basis increased (13% in 2005, 24% in
2007, P  0.0315). Those with chronic
woundsweremorelikelytobeadmitted
(87 vs. 78%, P  0.0256), and this co-
hort was also more likely to have coex-
isting renal impairment (64 vs. 38%,
P  0.0014).
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From the 379 patients recruited, 653
specimens were analyzed and 1,298 iso-
lates were detected (Table 1). Gram-
positive aerobic bacteria accounted for
77%ofisolateswithstaphylococci(43%),
streptococci (13%), and enterococci
(8%). The remainder of isolates were
gram-negative bacteria (22%), anaerobic
bacteria (1%), or fungal organisms
(0.4%). A greater proportion of gram-
positive infections was seen with acute
wounds (86 vs. 71%, P  0.001) and
those managed exclusively as outpatients
(84 vs. 76%, P  0.026). A single bacte-
rial isolate was cultured in 36% of
wounds. Acute wounds were more likely
to demonstrate monomicrobial growth
(41 vs. 32%, P  0.0174).
Methicillin-sensitive Staphylococcus
aureus (MSSA) was identiﬁed in 34% of
wounds, while MRSA was isolated in
23%. The frequency of MSSA infection
was greater in individuals with acute ul-
cers (50 vs. 22%, P  0.001) and those
exclusively receiving outpatient care (54
vs.31%,P0.001).Conversely,individ-
ualsreceivinginpatientcareweretwiceas
likely to have MRSA (24 vs. 12%, P 
0.01). A signiﬁcantly increased frequency
of MRSA infection was also demonstrated
in those with chronic ulcers (29 vs. 14%,
P  0.001) and CKD (27 vs. 17%, P 
0.002). Multivariate analyses established
that the greatest independent risk factor
for MRSA infection was chronic ulcer-
ation (odds ratio 2.31, P  0.001), then
inpatient care (2.19, P  0.027), and
CKD (1.49, P  0.042).
Streptococcal species were isolated
from 25% of wounds and were more prev-
alentamongindividualswithacutewounds
(30 vs. 21%, P  0.01) and normal renal
function (31 vs. 20%, P  0.009). How-
ever, Enterococcos was cultured more fre-
quently in individuals who had received
inpatient care (17 vs. 7%, P  0.021) and
hadnormalrenalfunction(19vs.12%,P
0.03). One Vancomycin-resistant Entero-
coccus isolate was detected in an inpatient
with both a chronic wound and CKD.
Gram-negative infections were more
frequent in individuals with chronic
wounds (58 vs. 25%, P  0.001) and
those managed as an inpatient (46 vs.
28%, P  0.002). Pseudomonas isolates
were more common in chronic wounds
(22 vs. 3%, P  0.001). Resistant gram-
negative “ESCAPPM” organisms (Entero-
bacter, Serratia, Citrobacter freundii,
Acinetobacter, Providencia spp, Proteus,
Morganella) with chromosomal-inducible
-lactamases were detected in 6% of
wound swabs with Proteus the most
prominent member.
CONCLUSIONS— This study inves-
tigated the wound microbiology of 379
DRFI, which were managed by a multidis-
ciplinary diabetic foot service. Gram-
positive cocci, especially staphylococci and
streptococci, were the predominant patho-
gens followed by gram-negative and anaer-
obic infections. MRSA infection, with its
associated increased morbidity and mortal-
ity, was detected in 23% of wounds (4,5).
Wound chronicity, inpatient care, and
CKD each independently predisposed
patients to MRSA infection. Hospital-
ization and prolonged wound duration
were alsoassociatedwithincreasinglycom-
plex polymicrobial infections that often in-
volved resistant gram-negative organisms.
By conﬁrming the microbiological pro-
ﬁle of DRFI and identifying risk factors for
MRSA infection, we believe this study aids
clinicians in the selection of empiric antibi-
otics. Antibiotic cover for MRSA should be
considered in patients with DRFI who have
one or more prior hospitalizations with the
same ulcer, chronic ulceration, or renal im-
pairment, especially in the acutely unwell
who cannot wait for culture and sensitivity
results. Furthermore, there is an ongoing
need for aggressive strategies to prevent the
spreadofresistantorganismswithemphasis
on early detection of at-risk patients, hand
hygiene, appropriate multidisciplinary care
to facilitate early wound healing, and judi-
cious outpatient management.
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